Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionFAK/Pyk2 tyrosine kinase inhibitor
Molecular Target Focal adhesion kinase (FAK)
Mechanism of ActionFocal adhesion kinase (FAK) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today